These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives. Schwingl PJ, Shelton J. Contraception; 1997 Mar 11; 55(3):125-9. PubMed ID: 9114999 [Abstract] [Full Text] [Related]
17. Cardiovascular effects of oral contraceptives: a review. Stubblefield PG. Int J Fertil; 1989 Mar 11; 34 Suppl():40-9. PubMed ID: 2576258 [Abstract] [Full Text] [Related]
18. Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States. Schwingl PJ, Ory HW, Visness CM. Am J Obstet Gynecol; 1999 Jan 11; 180(1 Pt 1):241-9. PubMed ID: 9914611 [Abstract] [Full Text] [Related]
19. Oral contraceptives and venous thromboembolism: a five-year national case-control study. Lidegaard Ø, Edström B, Kreiner S. Contraception; 2002 Mar 11; 65(3):187-96. PubMed ID: 11929640 [Abstract] [Full Text] [Related]